Uses of Sovalimus 0 1

This is an automatically translated article.

What is Sovalimus 0 1? This is a topical medication used by people with eczema. So, how to use sovalimus 0 1? What should be kept in mind when taking the drug? All will be in the article below.

1. What are the uses of Sovalimus 0 1 topical?

Sovalimus 0 1 topical medication contains the active ingredient tacrolimus 0.1% of Ha Tinh Pharmaceutical Joint Stock Company. The drug is manufactured for the short-term and long-term intermittent treatment of patients with moderate and severe atopic eczema. Alternative medicine to conventional alternative treatments with no indications and risks. Or treat patients who have not responded adequately or are intolerant of some conventional medications.

2. Indications for taking Sovalimus 0 1

Sovalimus topical 0.1% is used for adults and children over 15 years old in case of short-term treatment. Or intermittent long-term treatment of patients with moderate to severe atopic eczema for whom conventional alternative treatments are not indicated or the risk is high. Or treat patients who do not respond adequately. Or patients who are intolerant of some conventional medications.

3. Contraindications to the use of Sovalimus 0 1

Sovalimus 0.1% is contraindicated in some of the following cases:
People with a history of hypersensitivity to Tacrolimus or any component of the preparation. Children under 15 years old. Patients with Netherton's syndrome may increase the absorption of Tacrolimus into the body. The patient is suffering from bacterial dermatitis. Patients who are immunocompromised or at risk of increased percutaneous absorption of tacrolimus. Patients who have or are at risk of developing atopic dermatitis. Some cases need caution:
Patients with atopic eczema are prone to skin infections. If the patient has a clinical presence of a skin infection, the risks and benefits of using the drug should be weighed. While using Sovalimus topical, you should limit your skin's exposure to natural or artificial light. Sovalimus is applied on the skin without being absorbed by clothing. For individuals with Netherton syndrome, an increase in blood levels of Sovalimus has been reported after topical application. The possibility of increased systemic absorption of tacrolimus after topical administration of tacrolimus should be considered in patients with Netherton's syndrome. The safety of Tacrolimus topical in patients with generalized erythema has not been evaluated. If symptoms and signs of atopic eczema do not improve, further use should be considered. The safety and efficacy of topical tacrolimus topical in children under 2 years of age have not been established at this time. The use of Tacrolimus topical has not been studied in pregnant women. The drug should be used during pregnancy only if the benefits outweigh the risks. Tacrolimus is excreted in human milk following systemic administration. Therefore, caution should be exercised when using the drug during lactation.

4. Dosage of Sovalimus 0.1%

How to use
Sovalimus 0.1% topical drug for external application.
Dosage
Apply a thin layer of Sovalimus to the affected area twice a day and gently massage (For adults and children over 15 years old). Treatment should be continued for 1 more week after the signs and symptoms of dermatitis have resolved. The wound should not be covered while using Sovalimus.
Note: The above dosage is for reference only. The specific dose depends on the condition and the progression of the disease. For the best dosage, you should consult your doctor or healthcare professional.
What to do in case of overdose?
Sovalimus topical should not be taken orally. Oral administration of Sovalimus topical may lead to undesirable effects that have been identified with oral tacrolimus. If you accidentally take it orally, consult your doctor immediately.
What to do when you miss a dose?
If you forget a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and take your next dose at the scheduled time. Note that double the prescribed dose should not be taken.

5. Sovalimus 0.1% side effects

When using Sovalimus 0.1% topical you may experience unwanted effects (ADRs). These undesirable effects that may occur in < 1% of patients include: Skin burning, itching, skin infections, fever, allergic reactions, erythema herpes simplex, eczema, bronchial asthma, inflammation skin contact, pharyngitis, nausea, exfoliative dermatitis, increased ALT or AST, anaphylactoid reactions, angina, angioedema, anorexia, anxiety, arrhythmia, arthralgia, hyperbilirubinemia, chest pain , cellulitis, cheilitis, chills, constipation, increased creatinine, dehydration, depression, dizziness, dyspnea, ear pain, subcutaneous hemorrhage, edema, epistaxis, visual disturbances, increased decrease leukocytosis, gastritis, hyperglycemia, hyperglycemia, hypoxemia, migraine, neck pain, neuritis, tachycardia, peripheral vascular disorders, photosensitivity, discolouration skin, sweating, loss of taste, dental disease, vaginal monilia, vasodilatation and dizziness. Instructions on how to handle ADR: When experiencing side effects of the drug, the first thing to do is to stop using it and notify your doctor or go to the nearest medical facility for timely treatment.

6. Drug interactions

Tacrolimus topical is used topically on the skin. Concomitant use with other skin preparations and with UV therapy has not been studied. Concomitant use of Tacrolimus topical with UVA or UVB therapy or in combination with psoralen (PUVA) should be avoided.

Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.